British novelist Charles Dickens (1812-1870) sat in his study in Gads Hill near Rochester, Kent circa 1860. He wrote one of the best first lines in literature. Great opening lines to books set the ...
In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.
NCCN upgrades Trodelvy to category 1 preferred first-line therapy for metastatic TNBC with CPS <10 and no germline BRCA1/2 mutation. For PD-L1–positive metastatic TNBC (CPS ≥10), Trodelvy plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results